Member Info for nlondon1234

What happened?Last time the sp was at -4%ish.The bottom suddenly fell out.

Anyone know what the theft was part of?Was it part of one of the cancelled orders (?) cuz the amount stated is quite alot of money for the company right now still.

They just did that kinda odd, crowdfunding loan fo upto 500 grand, but 225 got away so far, secured against the 'floating' assets of the company too fairly recently with the high yield and the warrants.

Not a lth but saw the sp and read the rns.Un-be-llievable was my first thought too.Aim never fails to surprise and disappoint.Had assumed a discounted placing.Who runs these outfits?!Del and Rodney could only do a better job sometimes.Anyway sincere commiserations to lths as we‘ve all been there here or somewhere else,

I would think, if anyone would, Han**** could.That would be great shorter (possibly...!).. the han**** wiggle.

in younger people who have taken the pfizer or moderna shots.

https://www.reuters.com/business/healthcare-pharmaceuticals/us-panel-review-heart-inflammation-cases-after-pfizer-moderna-vaccines-2021-06-23/

Wow.Not the usual tils selloff (yet!haha) over the other side of the pond.They're even bidding it up.. so far!

Good news.Something new to follow.Interesting the adrs are up.I wonder if they will get sold down later.However, hopefully spells for an interesting next few months at least.

Blue day for the boys tonight too it seems chelsea!

When Curevac announced their bad trial results unfortunately, they were marked down heavily naturally losing their eu pre order revenue.The sp seems to have bounced back a decent amount since, so i'm guessing some 'bigger players/hedgefunds' are still positive over there and universal vaccine is the long term, covid big play now.Apparently curevac and GSK are aiming for mid 2022 for their 2nd gen vaccine if successful.
i guess they are hoping to potentially tweak their formula, if necessary, a little or whatever the good guys and girls there do and refocussing their efforts on their 2nd gen/universal vaccine.So sclp could be in the right space at exactly the right time now!I guess it's time to wait for the scientists to take centre stage and the science to play out.

2 of their 'home grown' vaccines invoked immune responses.One with 92%.28% effectiveness.

Yes.Marketwatch is pretty big in the us afaik.Whenever i search for any share us related marketwatch comes up near the top of the search rankings and in the news segment often.Afaik scan don't have an over the counter us listing however?

Should have gone with an aim listing.They would have got that away much easier.Perhaps it's the adrs complicating things like someone mentioned before?I'm just wondering who tils are employing to sort this all out.Surely they're not doing it themselves!!Anyway gotta remember i'm long this sometimes as the science is great!Get your very well paid lawyers to get moving gc.

If they get motoring with trials all the accustem issues and the huge bonus gc got will be forgiven!Let’s hope all the stars are finally aligning and patience will pay off sooner than later

Have to keep up with uipath’s next predicted numbers this year and whether they meet them or not.Prsm sp could inversely track that metric now its’s publicly available.

I don’t think the shorts will close as I believe it’s hedge fund pairs trade long uipath, short prsm.However also wouldn’t put it past someone shorting prsm for another reason..

Prsm hardly ever does anything nowadays apart from the necessary regulated accounting reports and trading updates etc..Thar’s been one of the common complaints in the last year or so from a few board lths.If this has been shorted, wsb aren’t coming to save her unfortunately.

Never thought prsm would get this much board ‘action’.The board’s been dead for yonks.

Well it was fun while it lasted

Their tech and pipeline valuation are still holding up fairly well considering the amount of eu preorders they had although they have a bunch of other drugs in clinical trials.Somebody's even 'buying the dip'.
Curevac highlighted preclinical data from CV2CoV, the second-generation vaccine it’s working on with GlaxoSmithKline on an investor call. In animal studies, that candidate induced antibody levels 10 times higher than CVnCoV at peak level after six weeks.

Or Lloyd Grossman..?;

Couldn't resist buying some tlsa too!